Skip to content
Tuesday, October 13, 2026
Hyper Palace Studio

Social Media Influencers Fueling Unofficial Trade for Unapproved Weight-Loss Drug

A shadow market for unapproved weight-loss medications is propelled by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Treatment Acquiring Popularity Online

The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged fat-burning properties. Viewers are encouraged to message these profiles privately for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Additionally, a robust market exists on Telegram, where groups with numerous of members share “before and after” images, administration instructions and assertions of rapid British shipping. Sellers market the substance there before redirecting customers to other platforms for transactions.

Learning About Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and chemists have warned that the distribution of what is still an unapproved drug in the UK is worrisome and could lead to users administering substances of unknown origin.

Some experts said the popularity for the experimental drug could be linked to the rising price of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach medicines, marketing, and customer laws, potentially leading to penalties, prosecution or imprisonment.

Platform Response and Material Removal

According to TikTok, the platform has taken down violative content and prohibited related hashtags and query recommendations. The organization said it was dedicated to maintaining the platform secure and allocating resources in enhancing enforcement strategies.

Online Marketplace Activities

Research also found groups with up to 9,000 members marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly displays groups with numerous of users, populated with images of slimming results, positive reviews and step-by-step guides for mixing or administering at home.

After minutes of joining one community, a vendor shared WhatsApp details, where most purchases occur. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about weight, medical conditions or past usage.

Product Information and Costs

Inside these groups, messages show dark colored parcels with postal service stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When questioned how much time a injector should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A representative for the messaging service stated it regularly moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering materials they can’t verify. Even if the research behind retatrutide is valid, these digital versions may not contain what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of an online medical service linked the surge in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.

Her team has already encountered individuals injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company experimental product not yet authorized … may expose patients to possibly significant health risks”.

About the author

Timothy Faulkner

A visionary digital artist and lead developer at Hyper Palace Studio, specializing in immersive web experiences and creative design solutions.

Hyper Palace Studio

Type to search articles.